Latest BrainZell News & Updates

See the latest news and media coverage for BrainZell. We track all announcements, press releases, and industry mentions in real time, all in one place.

BrainZell

AI-enabled drug discovery using human brain organoids

brainzell.com

Headquarters: Stockholm, Sweden
Founded year: 2020
Company type: Private company
Number of employees: 10
Industry: Pharmaceuticals

Last updated October 26

Latest news about BrainZell

In short: BrainZell advanced AI-driven brain organoid platforms through partnerships, leadership hires, and regulatory tailwinds for drug discovery.

Company announcements

October 26 BrainZell

BrainZell partners Stardots for Cross-AI collaboration

The partnership combines organoid research with human measurements to aid pharmaceutical drug development. The initiative focuses initially on bipolar disorder research using AI.

May 26 BrainZell

BrainZell collaborates on 3D neuroinflammation model

They partnered with another team to advance research in this field.

May 25 BrainZell

BrainZell returns from US investment summit

The company mapped 9 US locations and initiated collaboration with Mayo Clinic Research for CNS drug discovery.

May 11 BrainZell

BrainZell integrated functional microglia into brain organoids

The model enables study of neuroinflammation and drug screening.

Media coverage

October 26 Breakit

Stardots and BrainZell collaborate to connect human measurements with neural organoid research

AI, a research collaboration exploring how drug responses in patient-derived neural organoids relate to measurements in people. By combining their complementary technologies and AI expertise...

Never miss news about BrainZell

Track BrainZell and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BrainZell competitors & trending companies

Browse news for competitors to BrainZell and other trending companies.